Novo Nordisk’s Wegovy Gets US Approval for Liver Disease

Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy received Food and Drug Administration approval to treat a serious form of liver disease, beating rival Eli Lilly & Co. to the US market for the increasingly prevalent condition. The shot was clea... [350 chars]